Compare Stocks: VXRT, TLRY, LHSIF, and FENC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FENC Adherex Technologies	$10.30 -3.7%	$10.91	$5.65 ▼ $13.25	$362.05M	1.29	199,259 shs	160,720 shs
LHSIF Liberty Health Sciences	$1.14 -2.2%	$1.14	$0.23 ▼ $1.23	$392.01M	1.7	1.67 million shs	671,400 shs
TLRY Tilray Brands	$2.96 +11.7%	$3.70	$2.48 ▼ $15.70	$437.46M	2.04	4.27 million shs	12.56 million shs
VXRT Vaxart	$0.40	$0.46	$0.32 ▼ $0.84	$97.48M	1.15	474,519 shs	142,639 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FENC Adherex Technologies	+1.52%	+0.75%	+4.90%	+1.71%	+31.61%
LHSIF Liberty Health Sciences	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray Brands	+3.92%	-4.33%	-26.59%	-40.18%	-79.77%
VXRT Vaxart	-2.46%	+0.10%	-8.47%	-32.15%	+21.40%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FENC Adherex Technologies	$10.30 -3.7%	$10.91	$5.65 ▼ $13.25	$362.05M	1.29	199,259 shs	160,720 shs
LHSIF Liberty Health Sciences	$1.14 -2.2%	$1.14	$0.23 ▼ $1.23	$392.01M	1.7	1.67 million shs	671,400 shs
TLRY Tilray Brands	$2.96 +11.7%	$3.70	$2.48 ▼ $15.70	$437.46M	2.04	4.27 million shs	12.56 million shs
VXRT Vaxart	$0.40	$0.46	$0.32 ▼ $0.84	$97.48M	1.15	474,519 shs	142,639 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FENC Adherex Technologies	+1.52%	+0.75%	+4.90%	+1.71%	+31.61%
LHSIF Liberty Health Sciences	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray Brands	+3.92%	-4.33%	-26.59%	-40.18%	-79.77%
VXRT Vaxart	-2.46%	+0.10%	-8.47%	-32.15%	+21.40%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FENC Adherex Technologies	2.50	Moderate Buy	$17.00	65.00% Upside
LHSIF Liberty Health Sciences	0.00	N/A	N/A	N/A
TLRY Tilray Brands	2.38	Hold	$5.90	99.32% Upside
VXRT Vaxart	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest VXRT, TLRY, LHSIF, and FENC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/23/2026	TLRY Tilray Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/15/2026	FENC Adherex Technologies	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/9/2026	TLRY Tilray Brands	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$4.50 ➝ $4.00
10/8/2026	TLRY Tilray Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
10/5/2026	TLRY Tilray Brands	TD Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$4.70 ➝ $4.50
9/29/2026	TLRY Tilray Brands	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold ➝ Strong Sell
9/21/2026	TLRY Tilray Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/21/2026	TLRY Tilray Brands	ATB Cormark Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$8.00 ➝ $6.00
9/9/2026	FENC Adherex Technologies	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$16.00
8/24/2026	TLRY Tilray Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/12/2026	FENC Adherex Technologies	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$16.00 ➝ $18.00

(Data available from 11/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FENC Adherex Technologies	$44.64M	8.11	N/A	N/A	$1.04 per share	9.91
LHSIF Liberty Health Sciences	$37.77M	10.38	$0.04 per share	26.78	$0.31 per share	3.69
TLRY Tilray Brands	$915.45M	0.48	N/A	N/A	$13.68 per share	0.22
VXRT Vaxart	$237.26M	0.41	$0.10 per share	4.00	$0.37 per share	1.08

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FENC Adherex Technologies	-$9.74M	-$0.13	N/A	10.62	N/A	-6.09%	-5.71%	-2.37%	11/12/2026 (Estimated)
LHSIF Liberty Health Sciences	$16.80M	N/A	38.17	N/A	N/A	19.34%	9.51%	6.78%	N/A
TLRY Tilray Brands	-$121.40M	-$1.40	N/A	N/A	N/A	-16.91%	-10.39%	-7.38%	1/11/2027 (Estimated)
VXRT Vaxart	$16.33M	$0.16	2.50	N/A	N/A	15.88%	53.04%	20.85%	11/5/2026 (Estimated)

Latest VXRT, TLRY, LHSIF, and FENC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q3 2026	FENC Adherex Technologies	$0.09	N/A	N/A	N/A	$18.87 million	N/A
11/5/2026	Q3 2026	VXRT Vaxart	-$0.03	N/A	N/A	N/A	$27.20 million	N/A
10/8/2026	Q1 2027	TLRY Tilray Brands	-$0.1814	-$0.02	+$0.1614	-$0.32	$266.26 million	$257.15 million
8/13/2026	Q2 2026	FENC Adherex Technologies	$0.02	$0.05	+$0.03	$0.05	$16.21 million	$17.87 million
8/6/2026	Q2 2026	VXRT Vaxart	-$0.12	-$0.06	+$0.06	-$0.06	$26.21 million	$27.19 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FENC Adherex Technologies	N/A	N/A	N/A	N/A	N/A
LHSIF Liberty Health Sciences	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A
VXRT Vaxart	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FENC Adherex Technologies	N/A	5.85	5.66
LHSIF Liberty Health Sciences	N/A	2.93	0.72
TLRY Tilray Brands	0.17	1.88	1.11
VXRT Vaxart	N/A	1.60	1.60

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FENC Adherex Technologies	55.51%
LHSIF Liberty Health Sciences	N/A
TLRY Tilray Brands	9.35%
VXRT Vaxart	18.05%

Insider Ownership

Company	Insider Ownership
FENC Adherex Technologies	10.73%
LHSIF Liberty Health Sciences	N/A
TLRY Tilray Brands	1.60%
VXRT Vaxart	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FENC Adherex Technologies	35	35.14 million	31.37 million	Optionable
LHSIF Liberty Health Sciences	291	342.49 million	N/A	Not Optionable
TLRY Tilray Brands	3,595	147.79 million	145.42 million	Optionable
VXRT Vaxart	65	243.70 million	236.88 million	No Data

VXRT, TLRY, LHSIF, and FENC Headlines

Recent News About These Companies

Vaxart (VXRT) Projected to Release Earnings on Thursday

October 31, 2026 | americanbankingnews.com

Vaxart (VXRT) Projected to Announce Quarterly Earnings on Thursday

October 31, 2026 | marketbeat.com

Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET

October 29, 2026 | finance.yahoo.com

Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET

October 29, 2026 | globenewswire.com

Analyzing PainReform (NASDAQ:PRFX) & Vaxart (OTCMKTS:VXRT)

October 28, 2026 | americanbankingnews.com

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

October 19, 2026 | finance.yahoo.com

Vaxart's VXA-H5-02 Shows 100% Survival In H5N1 Ferret Study

October 8, 2026 | rttnews.com

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

October 8, 2026 | finance.yahoo.com

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

October 8, 2026 | globenewswire.com

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026 | finance.yahoo.com

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026 | globenewswire.com

Vaxart Secures New European Patent Covering Oral Norovirus Vaccine Technology

August 27, 2026 | finance.yahoo.com

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

August 26, 2026 | globenewswire.com

Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...

August 10, 2026 | finance.yahoo.com

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding

August 8, 2026 | seekingalpha.com

Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results

August 6, 2026 | markets.businessinsider.com

Vaxart Q2 2026 earnings preview

August 5, 2026 | msn.com

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

July 30, 2026 | finance.yahoo.com

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

July 30, 2026 | globenewswire.com

Vaxart to Participate in BTIG Biotechnology Conference 2026

July 21, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

VXRT, TLRY, LHSIF, and FENC Company Descriptions

Adherex Technologies NASDAQ:FENC

$10.30 -0.40 (-3.71%)

Closing price 03:59 PM Eastern

Extended Trading

$10.96 +0.66 (+6.43%)

As of 04:10 PM Eastern

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

Liberty Health Sciences OTCMKTS:LHSIF

$1.14 -0.03 (-2.17%)

As of 02/26/2021

Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis in the United States. The company offers medical cannabis in the State of Florida through the Florida Department of Health, office of medical marijuana use. As of January 21, 2021, it operated 29 dispensaries in Florida. The company is headquartered in Gainesville, Florida.

Tilray Brands NASDAQ:TLRY

$2.96 +0.31 (+11.70%)

Closing price 04:00 PM Eastern

Extended Trading

$2.98 +0.02 (+0.68%)

As of 05:32 PM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Vaxart OTCMKTS:VXRT

$0.40 0.00 (0.00%)

As of 03:59 PM Eastern

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VXRT, TLRY, LHSIF, and FENC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VXRT, TLRY, LHSIF, and FENC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VXRT, TLRY, LHSIF, and FENC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

VXRT, TLRY, LHSIF, and FENC Company Descriptions

Adherex Technologies NASDAQ:FENC

Liberty Health Sciences OTCMKTS:LHSIF

Tilray Brands NASDAQ:TLRY

Vaxart OTCMKTS:VXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VXRT, TLRY, LHSIF, and FENC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VXRT, TLRY, LHSIF, and FENC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VXRT, TLRY, LHSIF, and FENC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

VXRT, TLRY, LHSIF, and FENC Company Descriptions

Adherex Technologies NASDAQ:FENC

Liberty Health Sciences OTCMKTS:LHSIF

Tilray Brands NASDAQ:TLRY

Vaxart OTCMKTS:VXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools